Cargando…

Chinese SLE Treatment and Research Group (CSTAR) Registry 2009–2019: Major Clinical Characteristics of Chinese Patients with Systemic Lupus Erythematosus

OBJECTIVE: To describe the overall clinical characteristics of patients from the Chinese SLE Treatment and Research group (CSTAR) registry in the past 10 years. METHODS: CSTAR registry originated as a multicenter, consecutive, and prospective design launched in 2009. The data were collected online f...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Mengtao, Wang, Yanhong, Zhao, Jiuliang, Wang, Qian, Wang, Ziqian, Tian, Xinping, Zeng, Xiaofeng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Sciendo 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9524770/ https://www.ncbi.nlm.nih.gov/pubmed/36467897 http://dx.doi.org/10.2478/rir-2021-0001

Ejemplares similares

Sex differences in systemic lupus erythematosus (SLE): an inception cohort of the Chinese SLE Treatment and Research Group (CSTAR) registry XVII
por: Gui, Yinli, et al.
Publicado: (2022)

Chinese SLE Treatment and Research Group Registry (CSTAR) XIV: the subjective well-being of patients with systemic lupus erythematosus
por: Shi, Yue, et al.
Publicado: (2022)

Chinese SLE Treatment and Research Group Registry (CSTAR) XIII: prevalence and risk factors for chronic scarring alopecia in patients with systemic lupus erythematosus
por: Xiang, Yirong, et al.
Publicado: (2021)

Risk factors for avascular necrosis in patients with systemic lupus erythematosus: a multi-center cohort study of Chinese SLE Treatment and Research Group (CSTAR) Registry XXII
por: Cheng, Cheng, et al.
Publicado: (2023)

Long-term Outcomes of Patients with Systemic Lupus Erythematosus: A Multicenter Cohort Study from CSTAR Registry
por: Wang, Ziqian, et al.
Publicado: (2021)

Chinese SLE Treatment and Research group (CSTAR) registry: Clinical significance of thrombocytopenia in Chinese patients with systemic lupus erythematosus
por: Jiang, N., et al.
Publicado: (2019)

Annual Direct Cost and Cost-Drivers of Systemic Lupus Erythematosus: A Multi-Center Cross-Sectional Study from CSTAR Registry
por: Wang, Haiyan, et al.
Publicado: (2023)

Sirolimus versus tacrolimus for systemic lupus erythematosus treatment: results from a real-world CSTAR cohort study
por: Jiang, Nan, et al.
Publicado: (2022)

Chinese SLE Treatment and Research Group Registry: III. Association of Autoantibodies with Clinical Manifestations in Chinese Patients with Systemic Lupus Erythematosus
por: Li, Jing, et al.
Publicado: (2014)

Risk assessment in systemic lupus erythematosus-associated pulmonary arterial hypertension: CSTAR-PAH cohort study
por: Wang, Qian, et al.
Publicado: (2022)

2022 Chinese guideline for the management of pregnancy and reproduction in systemic lupus erythematosus
por: Tian, Xinping, et al.
Publicado: (2023)

A prognostic model for systemic lupus erythematosus-associated pulmonary arterial hypertension: CSTAR-PAH cohort study
por: Qu, Jingge, et al.
Publicado: (2023)

Chinese Systemic Lupus Erythematosus Treatment and Research Group Registry VI: Effect of Cigarette Smoking on the Clinical Phenotype of Chinese Patients with Systemic Lupus Erythematosus
por: Xu, Dong, et al.
Publicado: (2015)

Progress in the Pathogenesis and Treatment of Neuropsychiatric Systemic Lupus Erythematosus
por: Wang, Minhui, et al.
Publicado: (2022)

Long-Term Survival and Death Causes of Systemic Lupus Erythematosus in China: A Systemic Review of Observational Studies
por: Wang, Ziqian, et al.
Publicado: (2015)

The Challenges and Future Perspective for the Management of Systemic Lupus Erythematosus in China: A Concise Annual Report of 2020
por: Tian, Xinping, et al.
Publicado: (2022)

Clinical efficacy and safety of sirolimus in systemic lupus erythematosus: a real-world study and meta-analysis
por: Peng, Liying, et al.
Publicado: (2020)

Clinical efficacy of tacrolimus in systemic lupus erythematosus with various manifestations: a real-world study
por: Bai, Wei, et al.
Publicado: (2022)

Exploring the risk factors and prognosis of transverse myelitis in systemic lupus erythematosus
por: Wang, Minhui, et al.
Publicado: (2022)

Clinical Features and Outcomes of Neuropsychiatric Systemic Lupus Erythematosus in China
por: Zhang, Shangzhu, et al.
Publicado: (2021)

Clinical Characteristics of Systemic Lupus Erythematosus with Cirrhosis
por: You, Hanxiao, et al.
Publicado: (2020)

Chinese Registry of rheumatoid arthritis (CREDIT): II. prevalence and risk factors of major comorbidities in Chinese patients with rheumatoid arthritis
por: Jin, Shangyi, et al.
Publicado: (2017)

Thrombocytopenia Is an Independent Risk Factor for the Prognosis of Thrombotic Microangiopathy in Chinese Patients With Systemic Lupus Erythematosus
por: Yang, Fan, et al.
Publicado: (2021)

An invitation to Cstar-algebras
por: Arveson, William
Publicado: (1976)

The efficacy of Mycophenolate mofetil for the treatment of Chinese Takayasu’s arteritis
por: Li, Jing, et al.
Publicado: (2016)

The diagnostic and prognostic value of growth differentiation factor‐15 in systemic lupus erythematosus‐associated pulmonary arterial hypertension
por: Qian, Junyan, et al.
Publicado: (2023)

2020 Chinese Guidelines for the Diagnosis and Treatment of Systemic Lupus Erythematosus
por: Li, Mengtao, et al.
Publicado: (2020)

Cause of death in Chinese Takayasu arteritis patients
por: Li, Jing, et al.
Publicado: (2016)

Impact of pregnancy in patients with systemic lupus erythematosus-associated pulmonary arterial hypertension: case series and literature review
por: Li, Mucong, et al.
Publicado: (2022)

Chinese registry of rheumatoid arthritis (CREDIT) V: sex impacts rheumatoid arthritis in Chinese patients
por: Jiang, Nan, et al.
Publicado: (2022)

Cstar-algebras and Wstar-algebras
por: Sakai, Shôichirô
Publicado: (1971)

Pregnancy Outcomes in Chinese Patients with Systemic Lupus Erythematosus (SLE): A Retrospective Study of 109 Pregnancies
por: Ku, Ming, et al.
Publicado: (2016)

Immunoglobulin A Isotype of Antiphospholipid Antibodies Does Not Provide Added Value for the Diagnosis of Antiphospholipid Syndrome in a Chinese Population
por: Hu, Chaojun, et al.
Publicado: (2020)

Monoclonal Antibodies for Systemic Lupus Erythematosus (SLE) †
por: Ponticelli, Claudio, et al.
Publicado: (2010)

Malignancy in Systemic Lupus Erythematosus (SLE) Patients
por: Cader, Rizna Abdul, et al.
Publicado: (2018)

Progressive Multifocal Leukoencephalopathy in a Patient with Systemic Lupus Erythematosus
por: Qiao, Lin, et al.
Publicado: (2022)

Baseline Characteristics and Risk Factors of Pulmonary Arterial Hypertension in Systemic Lupus Erythematosus Patients
por: Huang, Can, et al.
Publicado: (2016)

Prevalence and diagnostic value of non-criteria antiphospholipid antibodies for antiphospholipid syndrome in Chinese patients
por: Li, Siting, et al.
Publicado: (2023)

Spectrum of Spondyloarthritis Among Chinese Populations
por: Zhang, Shangzhu, et al.
Publicado: (2022)

Liver involvement in juvenile systemic lupus erythematosus (SLE)
por: Mariniello, Generosa, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_r8tu9jef1ucnecrokall23dh6s